SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bhupesh Singla, Anuradha Chakraborti, Bal Krishan Sharma, Shweta Kapil, Yogesh K. Chawla, Sunil K. Arora, Ashim Das, Radha K. Dhiman, Ajay Duseja, Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patients, Molecular Biology Reports, 2014, 41, 7, 4689

    CrossRef

  2. 2
    Yun-Fan Liaw, Nancy Leung, Jia-Horng Kao, Teerha Piratvisuth, Edward Gane, Kwang-Hyub Han, Richard Guan, George K. K. Lau, Stephen Locarnini, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update, Hepatology International, 2008, 2, 3, 263

    CrossRef

  3. 3
    Mari Inada, Osamu Yokosuka, Current antiviral therapies for chronic hepatitis B, Hepatology Research, 2008, 38, 6
  4. 4
    Fabien Zoulim, Robert Perrillo, Hepatitis B: Reflections on the current approach to antiviral therapy, Journal of Hepatology, 2008, 48, S2

    CrossRef

  5. 5
    Fumitaka Suzuki, Hiromitsu Kumada, Interferon and lamivudine monotherapy on chronic hepatitis B in Japan, Hepatology Research, 2007, 37,
  6. 6
    Andreas Laras, John Koskinas, Evangelini Dimou, Ageliki Kostamena, Stephanos J. Hadziyannis, Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients, Hepatology, 2006, 44, 3
  7. 7
    Takeshi Okanoue, Masahito Minami, Update of research and management of hepatitis B, Journal of Gastroenterology, 2006, 41, 2, 107

    CrossRef

  8. 8
    Yun-Fan Liaw, Nancy Leung, Richard Guan, George K.K. Lau, Ismail Merican, Geoff McCaughan, Edward Gane, Jia-Horng Kao, Masao Omata, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update, Liver International, 2005, 25, 3
  9. 9
    Man-Fung Yuen, Danny Ka-Ho Wong, Simon Siu-Man Sum, He-Jun Yuan, John Chi-Hang Yuen, Annie On-On Chan, Benjamin Chun-Yu Wong, Ching-Lung Lai, Effect of Lamivudine Therapy on the Serum Covalently Closed-Circular (ccc) DNA of Chronic Hepatitis B Infection, The American Journal of Gastroenterology, 2005, 100, 5, 1099

    CrossRef

  10. 10
    Fabien Zoulim, New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA, Journal of Hepatology, 2005, 42, 3, 302

    CrossRef

  11. 11
    M.-C. Liu, M. Yu, N.-L. Zhang, W.-B. Gong, Y. Wang, W.-H. Piao, Q.-H. Wang, G.-Q. Wang, Dynamic analysis of hepatitis B virus DNA and its antigens in 2.2.15 cells, Journal of Viral Hepatitis, 2004, 11, 2
  12. 12
    Madhu Singh, Annie Dicaire, Adil E Wakil, Carolyn Luscombe, Stephen L Sacks, Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler™ real-time PCR, Journal of Virological Methods, 2004, 118, 2, 159

    CrossRef

  13. 13
    Ming-Liang He, Jun Wu, Ying Chen, Marie C Lin, George K.K Lau, Hsiang-fu Kung, A new and sensitive method for the quantification of HBV cccDNA by real-time PCR, Biochemical and Biophysical Research Communications, 2002, 295, 5, 1102

    CrossRef

  14. 14
    Sharon Lewin, Tomos Walters, Stephen Locarnini, Hepatitis B treatment: rational combination chemotherapy based on viral kinetic and animal model studies, Antiviral Research, 2002, 55, 3, 381

    CrossRef

  15. 15
    Suzane Kioko Ono, Naoya Kato, Yasushi Shiratori, Jun Kato, Tadashi Goto, Raymond F. Schinazi, Flair José Carrilho, Masao Omata, The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance, Journal of Clinical Investigation, 2001, 107, 4, 449

    CrossRef

  16. 16
    Teruyo Tomita, Osamu Yokosuka, Masami Tagawa, Hiromitsu Saisho, Shinobu Tamura, Ichiro Fukuda, Masao Omata, Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses, Journal of Hepatology, 2000, 32, 5, 850

    CrossRef

  17. 17
    Stephen Locarnini, Chris Birch, Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients, Journal of Hepatology, 1999, 30, 3, 536

    CrossRef

  18. 18
    Suzane Kioko Ono-Nita, Naoya Kato, Yasushi Shiratori, Keng-Hsin Lan, Hideo Yoshida, Flair José Carrilho, Masao Omata, Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors, Journal of Clinical Investigation, 1999, 103, 12, 1635

    CrossRef

  19. 19
    John M. Pezzuto, Cindy K. Angerhofer, Haider Mehdi, Structure and Chemistry (Part F), 1997,

    CrossRef

  20. 20
    S. I. Khakoo, P. N. Soni, D. Brown, G. M. Dusheiko, A clinical evaluation of a new method for HBV DNA quantitation in patients with chronic hepatitis B, Journal of Medical Virology, 1996, 50, 2
  21. 21
    Jo Dean, Scott Bowden, Stephen Locarnini, Reversion of duck hepatitis B virus DNA replication in vivo following cessation of treatment with the nucleoside analogue ganciclovir, Antiviral Research, 1995, 27, 1-2, 171

    CrossRef

  22. 22
    Carolyn Luscombe, John Pedersen, Scott Bowden, Stephen Locarnini, Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy, Liver, 1994, 14, 4
  23. 23
    Katsushi Ijichi, Keiji Mitamura, Setsuko Ida, Haruhiko Machida, Kaoru Shimada, In vivo antiviral effects of mismatched double-stranded RNA on duck hepatitis B virus, Journal of Medical Virology, 1994, 43, 2
  24. 24
    Harry L. A. Janssen, Yvonne A. M. Schoenmaker-Weber, Hans Kruining, Solko W. Schalm, Rudolf A. Heijtink, Quantitative assessment of hepatitis B virus DNA in chronic hepatitis B: comparison of two solution hybridization assays, Journal of Medical Virology, 1993, 40, 4
  25. 25
    William S. Mason, The problem of antiviral therapy for chronic hepadnavirus infections, Journal of Hepatology, 1993, 17, S137

    CrossRef

  26. 26
    Jianzhang Niu, Yanyan Wang, Robert Dixon, Scott Bowden, Ming Qiao, Leo Einck, Stephen Locarnini, The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus, Antiviral Research, 1993, 21, 2, 155

    CrossRef

  27. 27
    Kazuhiko Hosoda, Masao Omata, Osamu Yokosuka, Naoya Kato, Masao Ohto, Non-A, non-B chronic hepatitis is chronic hepatitis C: A sensitive assay for detection of hepatitis C virus RNA in the liver, Hepatology, 1992, 15, 5
  28. 28
    STEPHEN LOCARNINI, Design of new anti-viral agents for chronic hepatitis B virus infection, Journal of Gastroenterology and Hepatology, 1991, 6, S1
  29. 29
    Pierre Brissot, Christian Jacquelinet, Hervé Jouanolle, Véronique David, Dominique Guyader, Monique Guéguen, Martine Blayau, Gérard Lescoat, Michel Messner, Yves Deugnier, Short-term prednisolone followed by recombinant human α-interferon alone or combined with adenine-arabinoside in chronic hepatitis B, Journal of Hepatology, 1991, 12, 2, 181

    CrossRef

  30. 30
    Naomi Bishop, Gilda Civitico, Yanyan Wang, Kejian Guo, Chris Birch, Ian Gust, Stephen Locarnini, Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model, Journal of Medical Virology, 1990, 31, 2
  31. 31
    Gilda Civitico, Yanyan Wang, Carolyn Luscombe, Naomi Bishop, Gilda Tachedjian, Ian Gust, Stephen Locarnini, Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B Virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds, Journal of Medical Virology, 1990, 31, 2
  32. 32
    Shinya Nakajima, Tetsuo Kuroki, Machiko Shintani, Osamu Kurai, Tadashi Takeda, Shuhei Nishiguchi, Susumu Shiomi, Shuichi Seki, Kenzo Kobayashi, Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon, Hepatology, 1990, 12, 6
  33. 33
    Tsung-Teh Wu, Laura Coates, Carol E. Aldrics, Jesse Summers, William S. Mason, In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway, Virology, 1990, 175, 1, 255

    CrossRef

  34. 34
    H. Hofmann, W. Tuma, F.X. Heinz, C. Kunz, Relevance of Hepatitis B DNA Detection in Patient's Serum, Zentralblatt für Bakteriologie, 1990, 272, 4, 485

    CrossRef

  35. 35
    Hsiang Ju Lin, Hau Tim Chung, Ching Lung Lai, Susan Leong, Oi Sin Tam, Detection of supercoiled hepatitis B virus DNA and related forms by means of molecular hybridization to an oligonucleotide probe, Journal of Medical Virology, 1989, 29, 4
  36. 36
    William S. Mason, John M. Taylor, Experimental systems for the study of hepadnavirus and hepatitis delta virus infections, Hepatology, 1989, 9, 4
  37. 37
    P. Pontisso, F. Bortolotti, G. Fattovich, M.G. Ruvoletto, G. Realdi, A. Alberti, Hepatitis B virus DNA forms in the liver of chronically infected individuals, Journal of Hepatology, 1989, 9, 1, 29

    CrossRef

  38. 38
    SHINYA NAKAJIMA, TETSUO KUROKI, OSAMU KURAI, KENZO KOBAYASHI, SUKEO YAMAMOTO, Interferon receptors during treatment of chronic hepatitis B with interferon, Journal of Gastroenterology and Hepatology, 1989, 4, 5
  39. 39
    Hsiang Ju Lin, Advances in Clinical Chemistry Volume 27, 1989,

    CrossRef

  40. 40
    Georg Hess, Guido Gerken, Christian Weber, Michael Manns, Karl-Hermann Meyer Zum Büschenfelde, Reactivation of chronic type B hepatitis: The effect on expression of serum HBV-DNA and Pre-S encoded proteins, Journal of Medical Virology, 1988, 25, 2
  41. 41
    KIYOHIKO KURAI, SHIRO IINO, KAZUHIKO KOIKE, KEIJI MITAMURA, YASUO ENDO, HIROSHI OKA, The effects of antiviral agents on serum hepatitis B e antigen levels in chronic type B hepatitis, Journal of Gastroenterology and Hepatology, 1988, 3, 2
  42. 42
    R.A. Heijtink, P. Smal, F.J. ten Kate, J. Kruining, S.W. Schalm, Detection of HBV-DNA in liver biopsy and serum: Its significance in the selection of hepatitis B patients for antiviral therapy, Antiviral Research, 1987, 7, 6, 329

    CrossRef

  43. 43
    Katsutaro Hirota, Averell H. Sherker, Masao Omata, Osamu Yokosuka, Kunio Okuda, Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection, Hepatology, 1987, 7, 1
  44. 44
    Hepatitis B Virus DNA in Chronic Liver Disease, New England Journal of Medicine, 1987, 317, 2, 115

    CrossRef

  45. 45
    Georg Hess, Wolfram Gerlich, Guido Gerken, Michael Manns, Thomas H. Hütteroth, Karl-Hermann Meyer Zum Büschenfelde, The effect of recombinant α-interferon treatment on serum levels of hepatitis B virus-encoded proteins in man, Hepatology, 1987, 7, 4
  46. 46
    Masao Omata, Katsuo Uchiumi, Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B, Journal of Hepatology, 1986, 3, S65

    CrossRef

  47. 47
    Masao Omata, Katsutaro Hirota, Osamu Yokosuka, In vivo study of the mechanism of action of antiviral agents against hepadna virus replication in the liver, Journal of Hepatology, 1986, 3, S49

    CrossRef

  48. 48
    Gary L. Davis, Jay H. Hoofnagle, Interferon in viral hepatitis: Role in pathogenesis and treatment, Hepatology, 1986, 6, 5
  49. 49
    W. G. E. COOKSLEY, The impact of molecular biology on gastrointestinal and liver disease, Journal of Gastroenterology and Hepatology, 1986, 1, 5
  50. 50
    Stephen A. Locarnini, Michael Roggendorf, Other Hepadnaviridae (Avihepadnaviridae (DHBV) and Orthohepadnaviridae (WHV)),